Pentwater Capital Management LP
Source: SEC Form 13F · as of Mar 2026Pentwater Capital Management LP holds 6 biotech & pharma companies tracked by BioSniper, totaling $775.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
6
Total value held
$775.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Centessa Pharmaceuticals plc (CNTA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| CNTACentessa Pharmaceuticals plc | 8,170,000 | $324.5M |
| APLSApellis Pharmaceuticals, Inc. | 5,250,000 | $211.2M |
| FOLDAMICUS THERAPEUTICS, INC. | 14,000,000 | $202.4M |
| DAWNDay One Biopharmaceuticals, Inc. | 800,000 | $17.2M |
| GPCRStructure Therapeutics Inc. | 245,000 | $11.8M |
| RNAAtrium Therapeutics Inc. | 602,649 | $8.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.